Skip to main content

CL9 4.5 mg Pill - red capsule/oblong

Pill with imprint CL9 4.5 mg is Red, Capsule/Oblong and has been identified as Rivastigmine Tartrate 4.5 mg. It is supplied by Macleods Pharmaceuticals Limited.

Rivastigmine is used in the treatment of Parkinson's Disease; Alzheimer's Disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 4.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for CL9 4.5 mg

Rivastigmine tartrate 4.5 mg CL9 4.5 mg
Rivastigmine tartrate 4.5 mg CL9 4.5 mg

Rivastigmine Tartrate

CL9 4.5 mg
4.5 mg
Prescription only
Drug Class
Cholinesterase inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Macleods Pharmaceuticals Limited
National Drug Code (NDC)
Inactive Ingredients
magnesium stearate, microcrystalline cellulose, silicon dioxide, gelatin, titanium dioxide, sodium lauryl sulfate, ferric oxide red, ferric oxide yellow, hypromelloses

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.